Healthy adults
Conditions
Interventions
Take specified foods only or take both one packet test food (4g) and specified food with a glass of water or hot water.
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. 20 to 49 years old (at the time of submission of an informed consent document). 2. Men. 3. Those who have a BMI of less than 25 kg/m2 at the time of screening. 4. Those who have a fasting blood glucose level of less than 126 mg/dL at the time of screening. 5. Those who have a 120-min casual blood glucose level of less than 200 mg/dL at the time of screening. 6. Those who have an HbA1c value of less than 6.5% at the time of screening. 7. Smartphone or PC users (who can input their own data into the electronic diary). 8. Those who can receive sufficient explanation of the purpose and content of this study, who have ability to agree with the above explanation, who voluntarily participate in this study after coming to a better understanding, and who can give written informed consent. 9. Those who do not change or do not intend to change daily life habits during the study period.
Exclusion criteria
Exclusion criteria: 1. Those who are currently receiving some types of drug (except for the drugs that are taken as needed). 2. Those who are receiving nutrition therapy or physical therapy under a doctor's supervision. 3. Those who have or had a severe disease of the liver, kidneys, endocrine, heart ,gastrointestinal tract, respiratory system, blood, and metabolism. 4. Those who underwent gastrointestinal surgery. 5. Those who are currently taking the following products which affect glucose blood level: pharmaceutical products, health foods, or supplements. 6. Those who have a past and current medical history of drug or food allergy. 7. Those who may have allergic reactions to test food. 8. Those who work night shifts. 9. Smokers. 10. Heavy drinkers. 11. Those who are currently participating in another clinical trial or who had participated in another clinical trial conducted within a month prior to the submission of an informed consent document. 12. Those who experienced a feeling of being unwell or deterioration of health condition when they had blood drawn.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time-dependent changes of blood glucose levels. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time-dependent changes of blood insulin levels. | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed